ATE354095T1 - Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand - Google Patents

Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand

Info

Publication number
ATE354095T1
ATE354095T1 AT03799682T AT03799682T ATE354095T1 AT E354095 T1 ATE354095 T1 AT E354095T1 AT 03799682 T AT03799682 T AT 03799682T AT 03799682 T AT03799682 T AT 03799682T AT E354095 T1 ATE354095 T1 AT E354095T1
Authority
AT
Austria
Prior art keywords
prpsc
macrocyclic ligand
detecting prp
immunodetection
mal
Prior art date
Application number
AT03799682T
Other languages
English (en)
Inventor
Aly Moussa
Anthony William Coleman
Patrick Shahgaldian
Silva Eric Da
Ambroise Martin
Adina Nicoleta Lazar
Edwige Leclere
Marilyne Dupin
Herve Perron
Original Assignee
Afssa
Centre Nat Rech Scient
Univ Claude Bernard Lyon
Biomerieux Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afssa, Centre Nat Rech Scient, Univ Claude Bernard Lyon, Biomerieux Sa filed Critical Afssa
Application granted granted Critical
Publication of ATE354095T1 publication Critical patent/ATE354095T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT03799682T 2002-12-20 2003-12-19 Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand ATE354095T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0216383A FR2849205B1 (fr) 2002-12-20 2002-12-20 Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification

Publications (1)

Publication Number Publication Date
ATE354095T1 true ATE354095T1 (de) 2007-03-15

Family

ID=32406305

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03799682T ATE354095T1 (de) 2002-12-20 2003-12-19 Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand

Country Status (14)

Country Link
US (2) US7217530B2 (de)
EP (1) EP1573337B1 (de)
JP (1) JP2006510914A (de)
CN (1) CN100380125C (de)
AT (1) ATE354095T1 (de)
AU (1) AU2003299390B2 (de)
BR (1) BR0317080A (de)
DE (1) DE60311871T2 (de)
DK (1) DK1573337T3 (de)
ES (1) ES2282733T3 (de)
FR (1) FR2849205B1 (de)
MX (1) MXPA05006766A (de)
PT (1) PT1573337E (de)
WO (1) WO2004059322A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2849205B1 (fr) * 2002-12-20 2005-02-11 Afssa Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification
DE10328125A1 (de) * 2003-06-23 2005-01-13 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach spontaner Transformationsreaktion
FR2865279A1 (fr) * 2004-01-20 2005-07-22 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
FR2865280B1 (fr) 2004-01-20 2007-01-12 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
FR2888937B1 (fr) * 2005-07-21 2012-10-26 Biomerieux Sa Procede de detection des fcpa utilisant un agent d'agregation des fcpa et un agent de capture des agregats formes
WO2010001619A1 (ja) * 2008-07-04 2010-01-07 積水メディカル株式会社 免疫学的測定における感度増強方法又はヘモグロビンの影響回避方法
WO2013091074A1 (en) * 2011-12-21 2013-06-27 Uvic Industry Partnerships Inc. Method and array for identifying histone-code-related analytes
US10338037B2 (en) 2015-08-18 2019-07-02 Uvic Industry Partnerships Inc. Compounds and conjugates for identifying and separating post-translationally modified analytes
CA3084887A1 (en) 2019-06-25 2020-12-25 Uvic Industry Partnerships Inc. Compound and dimer complex embodiments for supramolecular sensing
CN113876760B (zh) * 2021-10-26 2022-12-23 南开大学 杯芳烃和/或杯芳烃的衍生物在制备治疗创伤性脑损伤的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312837A (en) * 1991-01-29 1994-05-17 Genelabs Technologies, Inc. Method of treating viral infections with aryl macrocyclic compounds
US5342934A (en) * 1992-06-19 1994-08-30 The Trustees Of Columbia University In The City Of New York Enantioselective receptor for amino acid derivatives, and other compounds
US6262257B1 (en) * 1996-04-05 2001-07-17 Board Of Regents, University Of Texas System Calixpyrroles, calixpyridinopyrroles and calixpyridines
US6054114A (en) * 1996-05-08 2000-04-25 Massachusetts Institute Of Technology Organometallic ligands for the localization and quantification of amyloid in vivo and in vitro
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
US6150172A (en) * 1999-01-08 2000-11-21 The United States Of America As Represented By The Secretary Of Agriculture Method and kit for extracting prion protein
AU5241100A (en) * 1999-09-28 2001-04-30 Universitat Zurich Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis
AU2001251358A1 (en) * 2000-04-05 2001-10-23 V.I. Technologies, Inc. Prion-binding ligands and methods of using same
DE10107083C2 (de) * 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
DE10119713A1 (de) * 2001-04-21 2002-10-24 Prionics Ag Zuerich Verfahren zur Untersuchung von Prion-Protein enthaltenden Proben auf das eventuelle Vorliegen der PrPSc-Form
FR2849205B1 (fr) * 2002-12-20 2005-02-11 Afssa Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification

Also Published As

Publication number Publication date
DE60311871D1 (de) 2007-03-29
US20060019311A1 (en) 2006-01-26
MXPA05006766A (es) 2006-02-17
DE60311871T2 (de) 2007-10-31
AU2003299390A8 (en) 2004-07-22
PT1573337E (pt) 2007-05-31
WO2004059322A8 (fr) 2005-07-14
US7217530B2 (en) 2007-05-15
CN1729397A (zh) 2006-02-01
DK1573337T3 (da) 2007-06-11
EP1573337B1 (de) 2007-02-14
US20070154885A1 (en) 2007-07-05
AU2003299390B2 (en) 2007-11-01
AU2003299390A1 (en) 2004-07-22
JP2006510914A (ja) 2006-03-30
EP1573337A1 (de) 2005-09-14
BR0317080A (pt) 2005-10-25
CN100380125C (zh) 2008-04-09
ES2282733T3 (es) 2007-10-16
FR2849205A1 (fr) 2004-06-25
FR2849205B1 (fr) 2005-02-11
WO2004059322A1 (fr) 2004-07-15

Similar Documents

Publication Publication Date Title
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
DK1734368T3 (da) Annexin-autoantistoffer anvendt som markörer for lungecancer
TW200801515A (en) Alzheimer's disease-specific alterations of the ERK1/ERK2 phosphorylation ratio- alzheimer's disease-specific molecular biomarkers (ADSMB)
ATE289685T1 (de) Verfahren zum nachweis von karzinomen in solubilisierten zervikalen körperproben
DK1573323T3 (da) Prion-proteinligander samt fremgangsmåder til anvendelse deraf
ATE438853T1 (de) Diagnostische testvorrichtung
DE602007003833D1 (de) Verbesserte vitamin-d-messung
RU2008136193A (ru) Детектирование рака по повышенным уровням bcl-2
ATE354095T1 (de) Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand
BRPI0311233A2 (pt) diagnóstico de carcinoma hepatocelular
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
ATE525462T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
DE69937835D1 (de) Antikörper für apoptosemarker und anwendungsverfahren
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
WO2007047029A3 (en) Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio as alzheimer's disease-specific molecular biomarkers (adsmb)
ATE462803T1 (de) Kit und verfahren zum nachweis von urothelkarzinom
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
PE20120592A1 (es) Metodo con biomarcadores para el seguimiento de un tratamiento
DE60301821D1 (de) Küvette für ein Lesegerät zur Bestimmung von Substanzen mittels der Evaneszenzfeldmethode
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
ATE398288T1 (de) Hoch-durchsatz prion tests

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties